How a Swedish Healthtech Company Is Transforming Medical Weight Loss
The market for medical weight loss has long suffered from the same persistent problems: high costs, fragmented access and bureaucratic friction. FagerCare, a Swedish healthtech company, is rewriting that script. With contemporary medications, a digital-first model and a team of experienced specialists, the company is delivering something that has been conspicuously absent – professional care without the hassle, without lock-in contracts and without breaking the bank.
The arrival of new GLP-1 medications – Mounjaro, Ozempic and their counterparts – fundamentally changed weight loss treatment. The clinical results are well-documented and impressive. Even so, access to these treatments has remained uneven, expensive and laden with bureaucratic obstacles. FagerCare was built on a deceptively simple idea: to make these treatments available to those who genuinely need them, on the right terms.
The FagerCare Approach
FagerCare is a digital healthcare service specialising in medical weight loss, with the latest pharmaceutical treatments at its centre. The target audience is adults struggling with excess weight who want professional medical support – without long queues, expensive private clinics or commitments to lengthy contracts.
The patient journey is deliberately streamlined. A digital consultation with a licensed physician, an individual assessment and – where treatment is appropriate – a prescription. From that point onwards, the patient takes whichever next step suits them best.
Among the most distinctive advantages of the model is the freedom to pick up medication at any pharmacy, including online pharmacies, choosing whichever option is cheapest at any given time. In a market where medication prices vary considerably between providers, this can mean significant annual savings. No lock-in. No hidden fees. Just care on the patient’s terms.
Expertise at the Core
The company stands on solid medical and technical foundations. Dr Frida Fagerdahl, a specialist physician in family medicine, brings extensive experience in metabolic health. She represents the clinical core of the company and ensures every patient’s treatment is anchored in science and individual consideration.
Specialist Tony Fagerdahl adds deep knowledge in health and treatment methodology, reinforcing the holistic view of patient wellbeing that defines the company’s work.
The digital backbone is the responsibility of Marcus Everflod, CEO of Searchminds. Searchminds builds and develops the company’s digital solutions – from platforms and patient flows to online visibility and presence. It is thanks to this partnership that FagerCare can deliver a seamless and secure digital experience for patients across Europe.
European Reach
FagerCare is already active in 25 European countries. This is not aspiration – it is today’s reality. For people living abroad, moving between countries or simply preferring to manage their health digitally, the difference is decisive. Whether the patient is in Stockholm, Málaga or Milan, the same high-quality care is available.
An Online Pharmacy and More on the Way
Over the coming year, FagerCare is expanding significantly. A partnership with an online pharmacy is in development and launching soon – a natural next step that further simplifies the entire chain from consultation to treatment. New services are being added continuously. The company is in motion, with the ambition to constantly widen what it can offer its patients.
The Longevity Dimension
One of the more compelling dimensions of FagerCare’s offering is its growing focus on longevity – a concept that has moved in recent years from niche biohacking culture to one of medicine’s most discussed frontiers. Longevity concerns the science and practice of extending not just lifespan, but above all the healthy and active part of life – the so-called healthspan.
Through combinations of biomarker analysis, nutritional and exercise intervention, and targeted supplements and medications, the approach is preventive rather than reactive. Research in the field – led by figures such as David Sinclair and Peter Attia – suggests that ageing itself can be slowed, and that we have far more control over our biological age than previously assumed. FagerCare integrates this perspective into its work and offers patients access to longevity-focused services as a complement to primary treatments. The thinking is to treat health as a long-term project, not just the management of acute conditions.
A New Clinic Opening This Autumn
Perhaps the most ambitious development is the opening of an exclusive physical and digital clinic, planned for the end of summer 2025. The clinic is aimed at patients with chronic conditions – those who have lived with pain, fatigue, autoimmune disorders or other long-term health issues and are seeking more in-depth, individualised support.
The concept rests on a conviction that under the right conditions, the body has a remarkable capacity to heal. The clinic will offer advanced assessment and tailor-made treatment plans, with the goal of not merely managing symptoms but actually addressing root causes.
The Case for FagerCare
In a landscape of healthcare options that are either hard to access, impersonal or prohibitively expensive, FagerCare offers something genuinely different. The combination of licensed medical expertise, digital accessibility, pricing flexibility and a steadily growing range of services positions the company as one of the most complete options for anyone serious about their health.
With operations in 31 countries, an online pharmacy on the way, an exclusive clinic in sight and a platform built by one of Europe’s most experienced digital companies – Searchminds – FagerCare is well placed for what comes next. More information is available at Fagercare.
Om skribenten
